Clinical Chemosensory Research: Needs, Future Directions, and Priorities - Agenda

Introductions

Goals and Agenda
Gary Beauchamp, Ph.D., and Susan Sullivan, Ph.D.

NIDCD Clinical Research Program
Gordon Hughes, M.D.

I. Training Opportunities

NIDCD Training Opportunities for the Clinician Scientist
Daniel Sklare, Ph.D.

Training Program Challenges
Jim Schwob, M.D., Ph.D.

Balancing a Dual Clinical/Research Career
Eric Holbrook, M.D.

Panel Discussion I

• Are there unmet needs with respect to training opportunities throughout different career stages?
• Are there specific areas or approaches that need research pipeline stimulation?

II. Clinical Research Opportunities

Smell and Taste Dysfunction: Clinical Priorities?
Don Leopold, M.D., and Linda Bartoshuk, Ph.D.

Gene Therapy: Potential to Treat Chemosensory Dysfunction
Jeff Martens, Ph.D.

Olfactory Stem Cell Research and Animal Models of Disease Processes
Jim Schwob, M.D., Ph.D., and Eric Holbrook, M.D.

Olfactory Function as a Biomarker for Neurodegenerative Diseases
Jay Gottfried, M.D., Ph.D.

Chemosensory Function Throughout Lifespan: Priorities for Studies of Pediatric, Aging, and Injured Populations?
Claire Murphy, Ph.D.

Measurement Development: Reliability and Validity?
Pam Dalton, M.P.H., Ph.D.

Taste and Feeding Behavior
Dana Small, Ph.D.

The Roles of the Chemical Senses in Nutrition
Rick Mattes, Ph.D.

Multisensory Processing and Flavor
Barry Green, Ph.D.

Other Areas for Discussion?
Panel

Lunch break

Panel Discussion II
Research Priorities and Recommendations

• What research areas are likely to have the biggest impact with respect to health care outcomes?
• What areas are ripe for clinical research or trials?
• What needs to be done to set the groundwork for future clinical research/trials?
• What are the obstacles and perceived needs with respect to resources, clinical assessments of chemosensory function, and technology development?

Adjourn